Publications

Add filters (0)

5 results

Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials.

August 25, 2025

Expert Rev Mol Diagn

Abstract INTRODUCTION Osteoarthritis (OA) involves an inflammatory component, presenting as synovitis and systemic low-grade inflammation. Preliminary evidence suggests that anti-inflammatory treatments may offer symptomatic and structural benefits in OA. More targeted approaches have been proposed and tested, but the means of identifying the clinical and molecular characteristics of patients with an inflammatory subtype remains unclear. […]

Read publication

From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers.

February 1, 2024

Expert Rev Mol Diagn

Abstract INTRODUCTION Osteoarthritis (OA) affects over 500 million people worldwide. OA patients are symptomatically treated, and current therapies exhibit marginal efficacy and frequently carry safety-risks associated with chronic use. No disease-modifying therapies have been approved to date leaving surgical joint replacement as a last resort. To enable effective patient care and successful drug development there […]

Read publication

Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment.

October 1, 2021

Expert Rev Mol Diagn

Abstract : Enzymatic cross-linking of the collagens within the extracellular matrix (ECM) catalyzed by enzymes such as lysyl oxidase (LOX) and lysyl oxidase like-enzymes 1-4 (LOXL), transglutaminase 2 (TG2), and peroxidasin (PXDN) contribute to fibrosis progression through extensive collagen cross-linking. Studies in recent years have begun elucidating the important role of collagen cross-linking in perpetuating […]

Read publication

Advances in the clinical use of collagen as biomarker of liver fibrosis.

September 1, 2020

Expert Rev Mol Diagn

Abstract INTRODUCTION Hepatic fibrosis is the excessive synthesis and deposition of extracellular matrix including collagen in the tissue. Chronic liver insult leads to progressive parenchymal damage, portal hypertension, and cirrhosis. Determination of hepatic collagen by invasive liver biopsy is the gold standard to estimate severity and stage of fibrosis. However, this procedure is associated with […]

Read publication

Blood and urinary collagen markers in osteoarthritis: markers of tissue turnover and disease activity.

January 1, 2020

Expert Rev Mol Diagn

Abstract : The need for diagnostic markers in osteoarthritis (OA) is acute and immediate, as sensitive and precise tools that monitor disease activity and treatment response are lacking. Collagens – types I, II, and III – are the skeleton of the extracellular matrix of joint tissues. Joint collagens are generally turned over at a low […]

Read publication